As of Feb 23
| -0.01 / -0.46%|
The 3 analysts offering 12-month price forecasts for MEI Pharma Inc have a median target of 2.50, with a high estimate of 6.50 and a low estimate of 1.75. The median estimate represents a +14.68% increase from the last price of 2.18.
The current consensus among 3 polled investment analysts is to Hold stock in MEI Pharma Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.